Exousia Bio, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Exousia Bio, Inc. (LMMY) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $0 for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-06-16
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-08-31 was $0.00.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-08-31 was $0.00.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-08-31 was -$6.54K.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-08-31 was -$8.32K.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$1.03K.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$6.83K.
- Exousia Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$2.25K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 4 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2026-02-28 | $0.00 10-Q · filed 2026-06-16 | |||||
| 2025-11-30 | $0.00 10-Q · filed 2026-03-17 | |||||
| 2025-08-31 | $0.00 10-Q · filed 2025-11-17 | |||||
| 2025-05-31 | -$1.03K 10-K · filed 2025-10-17 | |||||
| 2025-02-28 | $0.00 10-Q · filed 2026-06-16 | -$1.03K 10-Q · filed 2025-04-24 | ||||
| 2024-11-30 | $0.00 10-Q · filed 2026-03-17 | |||||
| 2024-08-31 | $0.00 10-Q · filed 2025-11-17 | |||||
| 2024-05-31 | -$6.83K 10-K · filed 2025-10-17 | |||||
| 2024-02-29 | -$6.83K 10-Q · filed 2025-04-24 | |||||
| 2023-11-30 | -$6.83K 10-Q · filed 2025-01-10 | |||||
| 2023-08-31 | -$6.54K 10-Q · filed 2024-10-11 | |||||
| 2023-05-31 | -$2.25K 10-K · filed 2024-08-30 | |||||
| 2023-02-28 | -$5.94K 10-Q · filed 2024-04-15 | |||||
| 2022-11-30 | -$8.76K 10-Q · filed 2024-01-16 | |||||
| 2022-08-31 | -$8.32K 10-Q · filed 2023-10-11 | |||||
| 2022-05-31 | $10.11K 10-K · filed 2023-09-01 |